GeneDx reports GUARDIAN genomic newborn screening study enrolls 30,000 infants, with 72.3% participation rate

Bitget2026/10/07 12:32

GeneDx flagged new evidence supporting genomic newborn screening, with study updates set for presentation at ICoNS on Oct. 7-8 in Boston. GUARDIAN study results indicated strong enrollment, consistent performance across diverse ancestries, meaningful clinical findings, alongside existing newborn screening. Screening also surfaced actionable inherited cardiac-risk cases, prompting preventive treatment in infants, with follow-on testing identifying at-risk relatives. BRIDGES-NBS, a nationwide NIH-funded initiative, is scheduled to start enrolling this month to test multi-state rollout inside public screening programs. Program design targets early-life treatable conditions, positioning GeneDx to support broader clinical adoption if feasibility and outcomes hold. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261007662968) on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Brent crude oil falls to $104 per barrel, down 0.2% in 24 hours.

Odaily星球日报•2026/10/07 17:09

The relevant page of Hyperliquid Labs lists 5 OTC buyer wallet addresses.

Odaily星球日报•2026/10/07 16:49

BUZZ - Preview: Levi's shares decline, market focuses on high-end jeans sales

On Wednesday, October 7, Levi Strauss (LEVI.N) shares fell 4.3% to $19.65 ahead of the company's quarterly earnings release after the market close. With consumer spending becoming more cautious, investors are closely watching the company's progress in entering the premium jeans market. According to data from the London Stock Exchange Group (LSEG), the apparel manufacturer—known for its jeans and casual wear—is expected to report third-quarter revenue growth of about 5% year-on-year to $1.62 billion, with adjusted earnings per share at $0.36, higher than last year's $0.34. Last quarter, the company raised its annual sales forecast, betting that its premium jeans would attract high-income consumers, though its earnings outlook disappointed some investors. Jefferies, in a preview report, anticipated the third-quarter results would be "solid" given strong demand for jeans, and pointed out that the appointment of a new chief financial officer signals continued focus on future global growth. On September 30, Levi's announced the appointment of John Vandemore as chief financial officer, effective November 1, 2026; Vandemore previously worked at Skechers, where he served as corporate controller and led the global finance team for the past nine years. In response to this news, Levi's shares have declined about 5% year-to-date and approximately 20% over the past 12 months. Out of 16 brokerage firms, 13 rate the stock as "strong buy" or "buy," while 3 have it as "hold"; the median target price remains at $27, unchanged over the last three months.

路透社•2026/10/07 16:46

This AI Stock Exploded 600% in a Year, Beating Nvidia and Micron

BeInCrypto•2026/10/07 16:21